首页 > 最新文献

Clinical Neuroradiology最新文献

英文 中文
Safety and Efficacy of LVIS Jr Stent-assisted Coiling of Intracranial Aneurysms in Small-diameter Parent Arteries : A Single-center Experience. LVIS Jr 支架辅助卷曲小直径母动脉颅内动脉瘤的安全性和有效性 :单中心经验。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-03-07 DOI: 10.1007/s00062-024-01397-0
Shuailong Shi, Shuhai Long, Fangfang Hui, Qi Tian, Zhuangzhuang Wei, Ji Ma, Jie Yang, Ye Wang, Xinwei Han, Tengfei Li

Objective: To investigate the safety and efficacy of LVIS Jr stent-assisted coiling (SAC) of intracranial aneurysms (IAs) in small-diameter parent arteries and determine the factors influencing incomplete aneurysm occlusion.

Material and methods: Clinical and imaging data of 130 patients with IAs in small-diameter parent arteries that were treated with LVIS Jr SAC were retrospectively analyzed. Stent apposition was evaluated by high-resolution flat detector CT, and aneurysm embolization density was evaluated using 2D-DSA. Perioperative complications were recorded. Multivariate logistic regression analyses were performed to determine possible factors for incomplete aneurysm occlusion.

Results: In this study, 130 patients (60 and 70 patients with ruptured and unruptured aneurysms, respectively) were successfully treated with LVIS Jr SAC. Immediate digital subtraction angiography (DSA) showed that the aneurysm occlusion was Raymond-Roy class I, II, IIIa, and IIIb in 93 (71.5%), 24 (18.5%), 8 (6.2%), and 5 (3.8%) cases, respectively. There were three cases of acute in-stent thrombosis and two cases of severe vasospasm observed during the perioperative period. The 6‑month follow-up angiograms indicated that complete aneurysm occlusion in 122 patients was 79.5% (97/122). Multivariate logistic regression analyses showed that an aneurysm size > 10.0 mm, parent artery mean diameter < 2.0 mm, and incomplete stent apposition at the aneurysm neck were possible risk factors for incomplete aneurysm occlusion.

Conclusion: The LVIS Jr SAC is effective for managing IAs in small-diameter parent arteries. An aneurysm size > 10.0 mm, parent artery mean diameter < 2.0 mm, and incomplete stent apposition at the aneurysm neck are possible risk factors for incomplete aneurysm occlusion.

目的研究LVIS Jr支架辅助卷曲术(SAC)治疗小直径母动脉颅内动脉瘤(IAs)的安全性和有效性,并确定影响动脉瘤不完全闭塞的因素:回顾性分析了130例接受LVIS Jr SAC治疗的小直径母动脉颅内动脉瘤患者的临床和影像学数据。通过高分辨率平板探测器CT评估支架位置,通过二维DSA评估动脉瘤栓塞密度。记录了围手术期并发症。进行了多变量逻辑回归分析,以确定动脉瘤未完全闭塞的可能因素:在这项研究中,130 名患者(分别为 60 名和 70 名动脉瘤破裂和未破裂患者)成功接受了 LVIS Jr SAC 治疗。即时数字减影血管造影(DSA)显示,93 例(71.5%)、24 例(18.5%)、8 例(6.2%)和 5 例(3.8%)动脉瘤闭塞为 Raymond-Roy I 级、II 级、IIIa 级和 IIIb 级。围手术期观察到 3 例急性支架内血栓形成和 2 例严重血管痉挛。6个月的随访血管造影显示,122例患者中动脉瘤完全闭塞率为79.5%(97/122)。多变量逻辑回归分析显示,动脉瘤大小大于 10.0 毫米、母动脉平均直径大于 10.0 毫米:LVIS Jr SAC 可有效控制小直径母动脉的内膜瘤。动脉瘤大小 > 10.0 毫米、母动脉平均直径
{"title":"Safety and Efficacy of LVIS Jr Stent-assisted Coiling of Intracranial Aneurysms in Small-diameter Parent Arteries : A Single-center Experience.","authors":"Shuailong Shi, Shuhai Long, Fangfang Hui, Qi Tian, Zhuangzhuang Wei, Ji Ma, Jie Yang, Ye Wang, Xinwei Han, Tengfei Li","doi":"10.1007/s00062-024-01397-0","DOIUrl":"10.1007/s00062-024-01397-0","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the safety and efficacy of LVIS Jr stent-assisted coiling (SAC) of intracranial aneurysms (IAs) in small-diameter parent arteries and determine the factors influencing incomplete aneurysm occlusion.</p><p><strong>Material and methods: </strong>Clinical and imaging data of 130 patients with IAs in small-diameter parent arteries that were treated with LVIS Jr SAC were retrospectively analyzed. Stent apposition was evaluated by high-resolution flat detector CT, and aneurysm embolization density was evaluated using 2D-DSA. Perioperative complications were recorded. Multivariate logistic regression analyses were performed to determine possible factors for incomplete aneurysm occlusion.</p><p><strong>Results: </strong>In this study, 130 patients (60 and 70 patients with ruptured and unruptured aneurysms, respectively) were successfully treated with LVIS Jr SAC. Immediate digital subtraction angiography (DSA) showed that the aneurysm occlusion was Raymond-Roy class I, II, IIIa, and IIIb in 93 (71.5%), 24 (18.5%), 8 (6.2%), and 5 (3.8%) cases, respectively. There were three cases of acute in-stent thrombosis and two cases of severe vasospasm observed during the perioperative period. The 6‑month follow-up angiograms indicated that complete aneurysm occlusion in 122 patients was 79.5% (97/122). Multivariate logistic regression analyses showed that an aneurysm size > 10.0 mm, parent artery mean diameter < 2.0 mm, and incomplete stent apposition at the aneurysm neck were possible risk factors for incomplete aneurysm occlusion.</p><p><strong>Conclusion: </strong>The LVIS Jr SAC is effective for managing IAs in small-diameter parent arteries. An aneurysm size > 10.0 mm, parent artery mean diameter < 2.0 mm, and incomplete stent apposition at the aneurysm neck are possible risk factors for incomplete aneurysm occlusion.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"587-595"},"PeriodicalIF":2.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Performance of Pointwise Encoding Time Reduction with Radial Acquisition Subtraction-based MR Angiography in the Follow-up of Intracranial Aneurysms after Clipping. 在颅内动脉瘤夹闭术后随访中使用基于径向采集减影的磁共振血管造影术缩短点状编码时间的诊断性能。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-03-08 DOI: 10.1007/s00062-024-01399-y
Inyoung Kim, Sung Jun Ahn, Mina Park, Bio Joo, Junhyung Kim, Sang Hyun Suh

Purpose: While follow-up assessment of clipped aneurysms (CAs) using magnetic resonance angiography (MRA) can be challenging due to susceptibility artifacts, a novel MRA sequence pointwise encoding time reduction with radial acquisition (PETRA) subtraction-based MRA, has been developed to reduce these artifacts. The aim of the study was to validate the diagnostic performance of PETRA-MRA by comparing it with digital subtraction angiography (DSA) as a reference for follow-up of CAs using a 3T MR scanner.

Methods: Patients with clipping who underwent both PETRA-MRA and DSA between September 2019 and December 2021 were retrospectively included. Two neuroradiologists independently reviewed with the reconstructed images of PETRA-MRA to assess the visibility of the arteries around the clips and aneurysm recurrence or remnants of CA using a 3-point scale. The diagnostic accuracy of PETRA-MRA was evaluated in comparison to DSA.

Results: The study included 34 patients (28 females, mean age 59 ± 9.6 years) with 48 CAs. The PETRA-MRA allowed visualization of the parent vessels around the clips in 98% of cases, compared to 39% with time-of-flight (TOF) MRA (p < 0.0001). The DSA confirmed 14 (29.2%) residual or recurrent aneurysms. The PETRA-MRA demonstrated a high accuracy, specificity, positive predictive value, and negative predictive value of 99.2%, 100%, 100%, and 97.8%, respectively, while the sensitivity was 66.7%.

Conclusion: This retrospective study demonstrates that PETRA-MRA provides excellent visibility of adjacent vessels near clips and has a high diagnostic accuracy in detecting aneurysm remnants or recurrences in CAs. Further prospective studies are warranted to establish its utility as a reliable alternative for follow-up after clipping.

目的:由于易感伪影的存在,使用磁共振血管造影(MRA)对夹闭动脉瘤(CA)进行随访评估具有挑战性。该研究的目的是将 PETRA-MRA 与数字减影血管造影术(DSA)进行比较,以验证 PETRA-MRA 的诊断性能,并将其作为使用 3T 磁共振扫描仪进行 CA 随访的参考:回顾性纳入2019年9月至2021年12月期间同时接受PETRA-MRA和DSA检查的剪切患者。两名神经放射科医生独立审查 PETRA-MRA 的重建图像,使用 3 级评分法评估夹子周围动脉的可见度以及动脉瘤复发或 CA 的残余。与 DSA 相比,对 PETRA-MRA 的诊断准确性进行了评估:研究共纳入 34 名患者(28 名女性,平均年龄为 59 ± 9.6 岁),共 48 个 CA。在 98% 的病例中,PETRA-MRA 可以看到夹子周围的母血管,而在飞行时间 (TOF) MRA 中,只有 39% 的病例可以看到夹子周围的母血管:这项回顾性研究表明,PETRA-MRA 能很好地显示夹片附近的邻近血管,在检测 CA 中的动脉瘤残余或复发方面具有很高的诊断准确性。有必要进行进一步的前瞻性研究,以确定其作为夹闭术后随访的可靠替代方法的实用性。
{"title":"Diagnostic Performance of Pointwise Encoding Time Reduction with Radial Acquisition Subtraction-based MR Angiography in the Follow-up of Intracranial Aneurysms after Clipping.","authors":"Inyoung Kim, Sung Jun Ahn, Mina Park, Bio Joo, Junhyung Kim, Sang Hyun Suh","doi":"10.1007/s00062-024-01399-y","DOIUrl":"10.1007/s00062-024-01399-y","url":null,"abstract":"<p><strong>Purpose: </strong>While follow-up assessment of clipped aneurysms (CAs) using magnetic resonance angiography (MRA) can be challenging due to susceptibility artifacts, a novel MRA sequence pointwise encoding time reduction with radial acquisition (PETRA) subtraction-based MRA, has been developed to reduce these artifacts. The aim of the study was to validate the diagnostic performance of PETRA-MRA by comparing it with digital subtraction angiography (DSA) as a reference for follow-up of CAs using a 3T MR scanner.</p><p><strong>Methods: </strong>Patients with clipping who underwent both PETRA-MRA and DSA between September 2019 and December 2021 were retrospectively included. Two neuroradiologists independently reviewed with the reconstructed images of PETRA-MRA to assess the visibility of the arteries around the clips and aneurysm recurrence or remnants of CA using a 3-point scale. The diagnostic accuracy of PETRA-MRA was evaluated in comparison to DSA.</p><p><strong>Results: </strong>The study included 34 patients (28 females, mean age 59 ± 9.6 years) with 48 CAs. The PETRA-MRA allowed visualization of the parent vessels around the clips in 98% of cases, compared to 39% with time-of-flight (TOF) MRA (p < 0.0001). The DSA confirmed 14 (29.2%) residual or recurrent aneurysms. The PETRA-MRA demonstrated a high accuracy, specificity, positive predictive value, and negative predictive value of 99.2%, 100%, 100%, and 97.8%, respectively, while the sensitivity was 66.7%.</p><p><strong>Conclusion: </strong>This retrospective study demonstrates that PETRA-MRA provides excellent visibility of adjacent vessels near clips and has a high diagnostic accuracy in detecting aneurysm remnants or recurrences in CAs. Further prospective studies are warranted to establish its utility as a reliable alternative for follow-up after clipping.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"597-603"},"PeriodicalIF":2.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intensive Blood Pressure Control After Endovascular Thrombectomy for Acute Ischemic Stroke: a Systematic Review and Meta-Analysis. 急性缺血性脑卒中血管内血栓切除术后的强化血压控制:系统综述与 Meta 分析。
IF 4.6 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-03-07 DOI: 10.1007/s00062-024-01391-6
Mohamed Abuelazm, Yehya Khildj, Ahmed A Ibrahim, Abdelrahman Mahmoud, Ahmed Mazen Amin, Ibrahim Gowaily, Ubaid Khan, Basel Abdelazeem, James Robert Brašić

Background and purpose: Optimal clinical outcome with successful recanalization from endovascular thrombectomy (EVT) requires optimal blood pressure (BP) management. We aimed to evaluate the efficacy and safety of the intensive BP target (< 140 mm Hg) versus the standard BP target (< 180 mm Hg) after EVT for acute ischemic stroke.

Methods: We conducted a systematic review and meta-analysis synthesizing evidence from randomized controlled trials (RCTs) obtained from PubMed, Embase Cochrane, Scopus, and WOS until September 7th, 2023. We used the fixed-effect model to report dichotomous outcomes using risk ratio (RR) and continuous outcomes using mean difference (MD), with a 95% confidence interval (CI).

Prospero id: CRD42023463206.

Results: We included four RCTs with 1559 patients. There was no difference between intensive BP and standard BP targets regarding the National Institutes of Health Stroke Scale (NIHSS) change after 24 h [MD: 0.44 with 95% CI (0.0, 0.87), P = 0.05]. However, the intensive BP target was significantly associated with a decreased risk of excellent neurological recovery (mRS ≤ 1) [RR: 0.87 with 95% CI (0.76, 0.99), P = 0.03], functional independence (mRS ≤ 2) [RR: 0.81 with 95% CI (0.73, 0.90), P = 0.0001] and independent ambulation (mRS ≤ 3) [RR: 0.85 with 95% CI (0.79, 0.92), P < 0.0001].

Conclusions: An intensive BP target after EVT is associated with worse neurological recovery and significantly decreased rates of functional independence and independent ambulation compared to the standard BP target. Therefore, the intensive BP target should be avoided after EVT for acute ischemic stroke.

背景和目的:血管内血栓切除术(EVT)成功再通的最佳临床结果需要最佳血压(BP)管理。我们旨在评估强化血压目标的有效性和安全性:我们对截至 2023 年 9 月 7 日从 PubMed、Embase Cochrane、Scopus 和 WOS 获取的随机对照试验(RCT)证据进行了系统回顾和荟萃分析。我们采用固定效应模型,以风险比(RR)报告二分结果,以平均差(MD)报告连续结果,并附带95%置信区间(CI):CRD42023463206.Results:结果:我们纳入了四项研究,共 1559 名患者。在 24 小时后美国国立卫生研究院卒中量表(NIHSS)的变化方面,强化血压目标值与标准血压目标值之间没有差异[MD:0.44,95% CI (0.0,0.87),P = 0.05]。然而,强化血压目标与神经功能极佳恢复(mRS ≤ 1)[RR:0.87,95% CI(0.76,0.99),P = 0.03]、功能独立(mRS ≤ 2)[RR:0.81,95% CI(0.73,0.90),P = 0.0001]和独立行走(mRS ≤ 3)[RR:0.85,95% CI(0.79,0.92),P] 的风险降低显著相关:与标准血压目标值相比,EVT 后的强化血压目标值与神经功能恢复较差、功能独立率和独立行走率显著降低有关。因此,急性缺血性卒中 EVT 后应避免使用强化血压目标值。
{"title":"Intensive Blood Pressure Control After Endovascular Thrombectomy for Acute Ischemic Stroke: a Systematic Review and Meta-Analysis.","authors":"Mohamed Abuelazm, Yehya Khildj, Ahmed A Ibrahim, Abdelrahman Mahmoud, Ahmed Mazen Amin, Ibrahim Gowaily, Ubaid Khan, Basel Abdelazeem, James Robert Brašić","doi":"10.1007/s00062-024-01391-6","DOIUrl":"10.1007/s00062-024-01391-6","url":null,"abstract":"<p><strong>Background and purpose: </strong>Optimal clinical outcome with successful recanalization from endovascular thrombectomy (EVT) requires optimal blood pressure (BP) management. We aimed to evaluate the efficacy and safety of the intensive BP target (< 140 mm Hg) versus the standard BP target (< 180 mm Hg) after EVT for acute ischemic stroke.</p><p><strong>Methods: </strong>We conducted a systematic review and meta-analysis synthesizing evidence from randomized controlled trials (RCTs) obtained from PubMed, Embase Cochrane, Scopus, and WOS until September 7th, 2023. We used the fixed-effect model to report dichotomous outcomes using risk ratio (RR) and continuous outcomes using mean difference (MD), with a 95% confidence interval (CI).</p><p><strong>Prospero id: </strong>CRD42023463206.</p><p><strong>Results: </strong>We included four RCTs with 1559 patients. There was no difference between intensive BP and standard BP targets regarding the National Institutes of Health Stroke Scale (NIHSS) change after 24 h [MD: 0.44 with 95% CI (0.0, 0.87), P = 0.05]. However, the intensive BP target was significantly associated with a decreased risk of excellent neurological recovery (mRS ≤ 1) [RR: 0.87 with 95% CI (0.76, 0.99), P = 0.03], functional independence (mRS ≤ 2) [RR: 0.81 with 95% CI (0.73, 0.90), P = 0.0001] and independent ambulation (mRS ≤ 3) [RR: 0.85 with 95% CI (0.79, 0.92), P < 0.0001].</p><p><strong>Conclusions: </strong>An intensive BP target after EVT is associated with worse neurological recovery and significantly decreased rates of functional independence and independent ambulation compared to the standard BP target. Therefore, the intensive BP target should be avoided after EVT for acute ischemic stroke.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"563-575"},"PeriodicalIF":4.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11339153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact Factor 2023 for Clinical Neuroradiology. 临床神经放射学》2023 年影响因子。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-08-21 DOI: 10.1007/s00062-024-01445-9
Martin Bendszus
{"title":"Impact Factor 2023 for Clinical Neuroradiology.","authors":"Martin Bendszus","doi":"10.1007/s00062-024-01445-9","DOIUrl":"10.1007/s00062-024-01445-9","url":null,"abstract":"","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":"34 3","pages":"529-530"},"PeriodicalIF":2.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11339139/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroimaging Abnormalities in Patients with Subacute Sclerosing Panencephalitis : Prospective Follow-up Study. 亚急性硬化性泛脑炎患者的神经影像异常:前瞻性随访研究
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-03-07 DOI: 10.1007/s00062-024-01396-1
D B Keerthiraj, Shweta Pandey, Ravindra Kumar Garg, Hardeep Singh Malhotra, Rajesh Verma, Praveen Kumar Sharma, Neeraj Kumar, Ravi Uniyal, Imran Rizvi, Sukriti Kumar, Anit Parihar, Amita Jain

Objective: This study aimed to assess the neuroimaging abnormalities and their progression in patients with Subacute sclerosing panencephalitis (SSPE) and identify clinical predictors of these imaging findings.

Methods: This prospective observational study evaluated clinical and neuroimaging features in patients with SSPE. Patients were categorized using Dyken's criteria, Jabbour's staging system, and the definition of fulminant SSPE. They underwent comprehensive clinical assessments, cerebrospinal fluid examination, Electroencephalogram (EEG), and Magnetic Resonance Imaging (MRI) scans. Treatment involved intrathecal interferon‑α and antiepileptic medications. Functional disability was assessed using the modified Barthel index. Follow-ups were performed at 6 months, including reassessment of Modified Barthel Index (MBI) and Jabbour's staging and EEG and MRI scans.

Results: The mean age was 13.9 ± 6.7 years, with males comprising 81.5% (44/54) of the cohort. Fulminant SSPE was noted in 33% (18/54) of cases. Disease duration before presentation varied significantly between fulminant and non-fulminant forms (p = 0.001). Neuroimaging abnormalities were more prevalent in JS III stage patients, with diffuse cerebral atrophy being a significant finding (p = 0.011). Basal ganglia involvement correlated with movement disorders. The 6‑month follow-up showed increased cerebral atrophy (p = 0.004). Increasing disease duration was an independent predictor of cerebral atrophy. An Intercomplex interval (ICI) of more than 10 minutes correlated with normal neuroimaging, 10 patients died within the study period, 8 of whom had fulminant SSPE.

Conclusion: Parieto-occipital White matter hyperintensity (WMH) is the most prevalent and sensitive neuroimaging finding for the diagnosis of SSPE. Despite interferon treatment, cerebral atrophy progressed in both aggressive and fulminant SSPE. Increasing disease duration is an independent predictor of cerebral atrophy.

研究目的本研究旨在评估亚急性硬化性泛脑炎(SSPE)患者的神经影像学异常及其进展情况,并确定这些影像学结果的临床预测因素:这项前瞻性观察研究评估了 SSPE 患者的临床和神经影像学特征。采用戴肯标准、贾布尔分期系统和暴发性 SSPE 的定义对患者进行分类。他们接受了全面的临床评估、脑脊液检查、脑电图(EEG)和磁共振成像(MRI)扫描。治疗包括鞘内干扰素α和抗癫痫药物。功能障碍采用改良巴特尔指数进行评估。6个月后进行随访,包括重新评估改良巴特尔指数(MBI)和贾布尔分期以及脑电图和磁共振成像扫描:患者平均年龄为(13.9 ± 6.7)岁,男性占81.5%(44/54)。33%的病例(18/54)出现了急性SSPE。暴发性和非暴发性病例发病前的病程差异显著(p = 0.001)。神经影像学异常在JS III期患者中更为普遍,弥漫性脑萎缩是一个重要发现(p = 0.011)。基底节受累与运动障碍有关。6 个月的随访显示脑萎缩加重(p = 0.004)。病程的延长是脑萎缩的独立预测因素。研究期间有10名患者死亡,其中8人患有急性SSPE:结论:椎旁-枕叶白质高密度(WMH)是诊断SSPE最常见、最敏感的神经影像学发现。尽管接受了干扰素治疗,但侵袭性和暴发性SSPE患者的脑萎缩仍在发展。病程的延长是脑萎缩的独立预测因素。
{"title":"Neuroimaging Abnormalities in Patients with Subacute Sclerosing Panencephalitis : Prospective Follow-up Study.","authors":"D B Keerthiraj, Shweta Pandey, Ravindra Kumar Garg, Hardeep Singh Malhotra, Rajesh Verma, Praveen Kumar Sharma, Neeraj Kumar, Ravi Uniyal, Imran Rizvi, Sukriti Kumar, Anit Parihar, Amita Jain","doi":"10.1007/s00062-024-01396-1","DOIUrl":"10.1007/s00062-024-01396-1","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the neuroimaging abnormalities and their progression in patients with Subacute sclerosing panencephalitis (SSPE) and identify clinical predictors of these imaging findings.</p><p><strong>Methods: </strong>This prospective observational study evaluated clinical and neuroimaging features in patients with SSPE. Patients were categorized using Dyken's criteria, Jabbour's staging system, and the definition of fulminant SSPE. They underwent comprehensive clinical assessments, cerebrospinal fluid examination, Electroencephalogram (EEG), and Magnetic Resonance Imaging (MRI) scans. Treatment involved intrathecal interferon‑α and antiepileptic medications. Functional disability was assessed using the modified Barthel index. Follow-ups were performed at 6 months, including reassessment of Modified Barthel Index (MBI) and Jabbour's staging and EEG and MRI scans.</p><p><strong>Results: </strong>The mean age was 13.9 ± 6.7 years, with males comprising 81.5% (44/54) of the cohort. Fulminant SSPE was noted in 33% (18/54) of cases. Disease duration before presentation varied significantly between fulminant and non-fulminant forms (p = 0.001). Neuroimaging abnormalities were more prevalent in JS III stage patients, with diffuse cerebral atrophy being a significant finding (p = 0.011). Basal ganglia involvement correlated with movement disorders. The 6‑month follow-up showed increased cerebral atrophy (p = 0.004). Increasing disease duration was an independent predictor of cerebral atrophy. An Intercomplex interval (ICI) of more than 10 minutes correlated with normal neuroimaging, 10 patients died within the study period, 8 of whom had fulminant SSPE.</p><p><strong>Conclusion: </strong>Parieto-occipital White matter hyperintensity (WMH) is the most prevalent and sensitive neuroimaging finding for the diagnosis of SSPE. Despite interferon treatment, cerebral atrophy progressed in both aggressive and fulminant SSPE. Increasing disease duration is an independent predictor of cerebral atrophy.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"577-585"},"PeriodicalIF":2.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MR Imaging Characteristics of Solitary Fibrous Tumors of the Orbit : Case Series of 18 Patients. 眼眶单发纤维性肿瘤的磁共振成像特征:18 例患者的病例系列。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-03-08 DOI: 10.1007/s00062-024-01400-8
Christoph Ziegenfuß, Natalie van Landeghem, Chiara Meier, Roman Pförtner, Anja Eckstein, Philipp Dammann, Patrizia Haubold, Johannes Haubold, Michael Forsting, Cornelius Deuschl, Isabel Wanke, Yan Li

Purpose: Solitary fibrous tumor (SFT) of the orbit is a rare tumor that was first described in 1994. We aimed to investigate its imaging characteristics that may facilitate the differential diagnosis between SFT and other types of orbital tumors.

Material and methods: Magnetic resonance imaging (MRI) data of patients with immunohistochemically confirmed orbital SFT from 2002 to 2022 at a tertiary care center were retrospectively analyzed. Tumor location, size, morphological characteristics, and contrast enhancement features were evaluated.

Results: Of the 18 eligible patients 10 were female (56%) with a mean age of 52 years. Most of the SFTs were oval-shaped (67%) with a sharp margin (83%). The most frequent locations were the laterocranial quadrant (44%), the extraconal space (67%) and the dorsal half of the orbit (67%). A flow void phenomenon was observed in nearly all cases (94%). On the T1-weighted imaging, tumor signal intensity (SI) was significantly lower than that of the retrobulbar fat and appeared predominantly equivalent (82%) to the temporomesial brain cortex, while on T2-weighted imaging its SI remained equivalent (50%) or slightly hyperintense to that of brain cortex. More than half of the lesions showed a homogeneous contrast enhancement pattern with a median SI increase of 2.2-fold compared to baseline precontrast imaging.

Conclusion: The SFT represents a rare orbital tumor with several characteristic imaging features. It was mostly oval-shaped with a sharp margin and frequently localized in the extraconal space and dorsal half of the orbit. Flow voids indicating hypervascularization were the most common findings.

目的:眼眶孤立性纤维瘤(SFT)是一种罕见的肿瘤,于1994年首次被描述。我们旨在研究其影像学特征,以便于鉴别诊断 SFT 和其他类型的眼眶肿瘤:我们对一家三级医疗中心 2002 年至 2022 年期间经免疫组化确诊的眼眶 SFT 患者的磁共振成像(MRI)数据进行了回顾性分析。对肿瘤位置、大小、形态特征和对比增强特征进行了评估:18名符合条件的患者中有10名女性(56%),平均年龄为52岁。大多数 SFT 为椭圆形(67%),边缘锐利(83%)。最常见的位置是后颅象限(44%)、骨膜外间隙(67%)和眶背半部(67%)。几乎所有病例(94%)都出现了血流空洞现象。在T1加权成像中,肿瘤信号强度(SI)明显低于球后脂肪,主要与颞侧大脑皮质相当(82%),而在T2加权成像中,其SI仍与大脑皮质相当(50%)或轻微高强。一半以上的病变呈均匀对比增强模式,与对比前的基线成像相比,中位SI增加了2.2倍:结论:SFT是一种罕见的眼眶肿瘤,具有多种特征性影像学表现。它大多呈椭圆形,边缘锐利,常位于眶外间隙和眼眶背半部。最常见的发现是显示血管过度扩张的血流空洞。
{"title":"MR Imaging Characteristics of Solitary Fibrous Tumors of the Orbit : Case Series of 18 Patients.","authors":"Christoph Ziegenfuß, Natalie van Landeghem, Chiara Meier, Roman Pförtner, Anja Eckstein, Philipp Dammann, Patrizia Haubold, Johannes Haubold, Michael Forsting, Cornelius Deuschl, Isabel Wanke, Yan Li","doi":"10.1007/s00062-024-01400-8","DOIUrl":"10.1007/s00062-024-01400-8","url":null,"abstract":"<p><strong>Purpose: </strong>Solitary fibrous tumor (SFT) of the orbit is a rare tumor that was first described in 1994. We aimed to investigate its imaging characteristics that may facilitate the differential diagnosis between SFT and other types of orbital tumors.</p><p><strong>Material and methods: </strong>Magnetic resonance imaging (MRI) data of patients with immunohistochemically confirmed orbital SFT from 2002 to 2022 at a tertiary care center were retrospectively analyzed. Tumor location, size, morphological characteristics, and contrast enhancement features were evaluated.</p><p><strong>Results: </strong>Of the 18 eligible patients 10 were female (56%) with a mean age of 52 years. Most of the SFTs were oval-shaped (67%) with a sharp margin (83%). The most frequent locations were the laterocranial quadrant (44%), the extraconal space (67%) and the dorsal half of the orbit (67%). A flow void phenomenon was observed in nearly all cases (94%). On the T1-weighted imaging, tumor signal intensity (SI) was significantly lower than that of the retrobulbar fat and appeared predominantly equivalent (82%) to the temporomesial brain cortex, while on T2-weighted imaging its SI remained equivalent (50%) or slightly hyperintense to that of brain cortex. More than half of the lesions showed a homogeneous contrast enhancement pattern with a median SI increase of 2.2-fold compared to baseline precontrast imaging.</p><p><strong>Conclusion: </strong>The SFT represents a rare orbital tumor with several characteristic imaging features. It was mostly oval-shaped with a sharp margin and frequently localized in the extraconal space and dorsal half of the orbit. Flow voids indicating hypervascularization were the most common findings.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"605-611"},"PeriodicalIF":2.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11338966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits of First Pass Recanalization in Basilar Strokes Based on Initial Clinical Severity. 基于初始临床严重程度的基底动脉脑卒中首次再通的益处
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-09-01 Epub Date: 2024-02-22 DOI: 10.1007/s00062-024-01392-5
Vincent Brissette, Danielle Carole Roy, Mobin Jamal, Maria Fahmy, Adrien Guenego, Joud Fahed, Michel Shamy, Dar Dowlatshahi, Robert Fahed

Purpose: Randomized trials demonstrating the benefits of thrombectomy for basilar artery occlusions have enrolled an insufficient number of patients with a National Institutes for Health Stroke Scale (NIHSS) score < 10 and shown discrepant results for patients with an NIHSS > 20. Achieving a first pass recanalization (FPR) improves clinical outcomes in stroke. We aimed to evaluate the effect of the FPR on outcomes among basilar artery occlusion patients, characterized by prethrombectomy initial NIHSS score.

Methods: We retrospectively analyzed the Endovascular Treatment in Ischemic Stroke (ETIS) registry of 279 basilar artery occlusion patients treated with thrombectomy from 6 participating centers. We compared the 90-day clinical outcomes of achieving a FPR versus no FPR, categorized by initial clinical severity: mild (NIHSS < 10), moderate (NIHSS 10-20) and severe (NIHSS > 20). We used Poisson regression with robust error variance to determine the effect of the NIHSS score on the association between FPR and outcomes.

Results: The FPR patients with NIHSS < 10 or NIHSS 10-20 were more likely to have a favorable clinical outcome (modified Rankin scale, mRS 0-3) than non-FPR patients (relative risk, RR = 1.32, 95% confidence interval, CI: 1.04, 1.66, p-value = 0.0213, and RR = 1.79, 95% CI: 1.26, 2.53, p-value = 0.0011, respectively). A similar benefit was not found in patients with severe symptoms. We found a significantly lower risk of poor clinical outcome (mRS 4-6) in FPR patients with NIHSS 10-20, but not among patients with an NIHSS > 20.

Conclusion: Achieving a FPR in basilar artery occlusion patients with mild (NIHSS < 10) or moderate (NIHSS 10-20) symptoms is associated with better clinical outcomes, but not in patients with severe symptoms. These results support the importance of further clinical trials on the benefits of thrombectomy in severe strokes.

目的:证明血栓切除术治疗基底动脉闭塞获益的随机试验并未充分纳入美国国立卫生研究院卒中量表(NIHSS)评分为 20 分的患者。实现首次再通畅(FPR)可改善卒中的临床预后。我们的目的是评估 FPR 对基底动脉闭塞患者预后的影响,基底动脉闭塞患者的特征是血栓切除术前初始 NIHSS 评分:我们回顾性分析了缺血性卒中血管内治疗(ETIS)登记册中来自 6 个参与中心的 279 名接受血栓切除术治疗的基底动脉闭塞患者。我们比较了达到 FPR 与未达到 FPR 的 90 天临床结果,按初始临床严重程度分类:轻度(NIHSS 20)。我们使用带有稳健误差方差的泊松回归来确定 NIHSS 评分对 FPR 与预后之间关系的影响:NIHSS为20分的FPR患者:基底动脉闭塞患者的轻度(NIHSS
{"title":"Benefits of First Pass Recanalization in Basilar Strokes Based on Initial Clinical Severity.","authors":"Vincent Brissette, Danielle Carole Roy, Mobin Jamal, Maria Fahmy, Adrien Guenego, Joud Fahed, Michel Shamy, Dar Dowlatshahi, Robert Fahed","doi":"10.1007/s00062-024-01392-5","DOIUrl":"10.1007/s00062-024-01392-5","url":null,"abstract":"<p><strong>Purpose: </strong>Randomized trials demonstrating the benefits of thrombectomy for basilar artery occlusions have enrolled an insufficient number of patients with a National Institutes for Health Stroke Scale (NIHSS) score < 10 and shown discrepant results for patients with an NIHSS > 20. Achieving a first pass recanalization (FPR) improves clinical outcomes in stroke. We aimed to evaluate the effect of the FPR on outcomes among basilar artery occlusion patients, characterized by prethrombectomy initial NIHSS score.</p><p><strong>Methods: </strong>We retrospectively analyzed the Endovascular Treatment in Ischemic Stroke (ETIS) registry of 279 basilar artery occlusion patients treated with thrombectomy from 6 participating centers. We compared the 90-day clinical outcomes of achieving a FPR versus no FPR, categorized by initial clinical severity: mild (NIHSS < 10), moderate (NIHSS 10-20) and severe (NIHSS > 20). We used Poisson regression with robust error variance to determine the effect of the NIHSS score on the association between FPR and outcomes.</p><p><strong>Results: </strong>The FPR patients with NIHSS < 10 or NIHSS 10-20 were more likely to have a favorable clinical outcome (modified Rankin scale, mRS 0-3) than non-FPR patients (relative risk, RR = 1.32, 95% confidence interval, CI: 1.04, 1.66, p-value = 0.0213, and RR = 1.79, 95% CI: 1.26, 2.53, p-value = 0.0011, respectively). A similar benefit was not found in patients with severe symptoms. We found a significantly lower risk of poor clinical outcome (mRS 4-6) in FPR patients with NIHSS 10-20, but not among patients with an NIHSS > 20.</p><p><strong>Conclusion: </strong>Achieving a FPR in basilar artery occlusion patients with mild (NIHSS < 10) or moderate (NIHSS 10-20) symptoms is associated with better clinical outcomes, but not in patients with severe symptoms. These results support the importance of further clinical trials on the benefits of thrombectomy in severe strokes.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":"555-562"},"PeriodicalIF":2.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient Horner's Syndrome Following CT-Guided C7 Nerve Root Block-A Case Report. CT 引导下 C7 神经根阻滞后的一过性霍纳氏综合征--病例报告。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-08-30 DOI: 10.1007/s00062-024-01453-9
Leonhard Mann, Valentina Correa, Elke Hattingen, Christophe T Arendt
{"title":"Transient Horner's Syndrome Following CT-Guided C7 Nerve Root Block-A Case Report.","authors":"Leonhard Mann, Valentina Correa, Elke Hattingen, Christophe T Arendt","doi":"10.1007/s00062-024-01453-9","DOIUrl":"https://doi.org/10.1007/s00062-024-01453-9","url":null,"abstract":"","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142114001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trevo 3 Mm and/or AXS Catalyst 5 for the Treatment of Medium Distal Vessel Occlusion Stroke-results from the ASSIST Registry. Trevo 3 毫米和/或 AXS Catalyst 5 用于治疗中远端血管闭塞性中风--来自 ASSIST 登记处的结果。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-08-23 DOI: 10.1007/s00062-024-01450-y
Nikolaos Ntoulias, Alex Brehm, Salvador Miralbés, Bharath Naravetla, Alejandro Spiotta, Christian Loehr, Mario Martínez-Galdámez, Ryan McTaggart, Luc Defreyne, Pedro Vega, Osama O Zaidat, Lori Lyn Price, David S Liebeskind, Markus Möhlenbruch, Rishi Gupta, Marios-Nikos Psychogios

Background: The effect of endovascular therapy (EVT) on the outcome of stroke patients with a medium distal vessel occlusion (MDVO) is unclear. We report the results of MDVO patients treated with the 3 mm Trevo stent retriever (SR) and/or the AXS Catalyst 5 distal access catheter.

Methods: Data was derived from a prospective, multicenter global registry (ASSIST registry) which enrolled patients treated with operator preferred EVT technique at 71 sites from January 2019 to January 2022. Three techniques were assessed: SR classic, direct aspiration, and a combined approach. Additional inclusion criteria were (a) EVT performed with the 3 mm Trevo SR and/or AXS Catalyst 5 distal access catheter on the first pass and (b) an occlusion of the M2 segment or M3 segment of the middle cerebral artery or the A1, A2 or A3 segment of the anterior cerebral artery. The primary outcome was achieving an expanded Thrombolysis in Cerebral Infarction (eTICI) score of 2c or 3 on the first pass, with the primary technique as adjudicated by core lab. The primary clinical outcome measure was a 90-day modified Rankin Scale (mRS) score of 0-2.

Results: A total of 155 patients (10.4% of the ASSIST population) were included. Most patients had an M2 occlusion (93.5%). First pass eTICI reperfusion was achieved in 43.1% of the patients. No modifying effect of the frontline technique was found. The rate of mRS 0-2 (overall 65.0%) did not significantly differ between groups.

Conclusion: The data suggests that the Trevo 3 mm SR and/or the AXS Catalyst 5 may be an option to treat medium distal vessel occlusion, but more data is needed to demonstrate safety and efficacy in this patient cohort. Further improvements are needed regarding materials and techniques to improve reperfusion results in this patient cohort in the future.

背景:血管内治疗(EVT)对中远端血管闭塞(MDVO)脑卒中患者预后的影响尚不明确。我们报告了使用 3 毫米 Trevo 支架回取器(SR)和/或 AXS Catalyst 5 远端通路导管治疗 MDVO 患者的结果:数据来自一个前瞻性、多中心全球登记处(ASSIST 登记处),该登记处从 2019 年 1 月至 2022 年 1 月在 71 个地点登记了使用操作者首选 EVT 技术治疗的患者。对三种技术进行了评估:SR经典技术、直接抽吸技术和联合方法。其他纳入标准包括:(a) 首次使用 3 毫米 Trevo SR 和/或 AXS Catalyst 5 远端入路导管进行 EVT;(b) 大脑中动脉 M2 段或 M3 段或大脑前动脉 A1、A2 或 A3 段闭塞。主要研究结果是通过核心实验室评定的主要技术,在首次通液时达到扩大脑梗塞溶栓(eTICI)2c 或 3 分。主要临床疗效指标为 90 天改良兰金量表(mRS)评分 0-2 分:共纳入 155 名患者(占 ASSIST 患者总数的 10.4%)。大多数患者为 M2 闭塞(93.5%)。43.1%的患者实现了首次eTICI再灌注。没有发现前线技术有任何调节作用。两组患者的 mRS 0-2 比率(总体 65.0%)无明显差异:这些数据表明,Trevo 3 mm SR 和/或 AXS Catalyst 5 可能是治疗中远端血管闭塞的一种选择,但还需要更多数据来证明这种患者群的安全性和有效性。未来还需要进一步改进材料和技术,以改善这类患者的再灌注效果。
{"title":"Trevo 3 Mm and/or AXS Catalyst 5 for the Treatment of Medium Distal Vessel Occlusion Stroke-results from the ASSIST Registry.","authors":"Nikolaos Ntoulias, Alex Brehm, Salvador Miralbés, Bharath Naravetla, Alejandro Spiotta, Christian Loehr, Mario Martínez-Galdámez, Ryan McTaggart, Luc Defreyne, Pedro Vega, Osama O Zaidat, Lori Lyn Price, David S Liebeskind, Markus Möhlenbruch, Rishi Gupta, Marios-Nikos Psychogios","doi":"10.1007/s00062-024-01450-y","DOIUrl":"https://doi.org/10.1007/s00062-024-01450-y","url":null,"abstract":"<p><strong>Background: </strong>The effect of endovascular therapy (EVT) on the outcome of stroke patients with a medium distal vessel occlusion (MDVO) is unclear. We report the results of MDVO patients treated with the 3 mm Trevo stent retriever (SR) and/or the AXS Catalyst 5 distal access catheter.</p><p><strong>Methods: </strong>Data was derived from a prospective, multicenter global registry (ASSIST registry) which enrolled patients treated with operator preferred EVT technique at 71 sites from January 2019 to January 2022. Three techniques were assessed: SR classic, direct aspiration, and a combined approach. Additional inclusion criteria were (a) EVT performed with the 3 mm Trevo SR and/or AXS Catalyst 5 distal access catheter on the first pass and (b) an occlusion of the M2 segment or M3 segment of the middle cerebral artery or the A1, A2 or A3 segment of the anterior cerebral artery. The primary outcome was achieving an expanded Thrombolysis in Cerebral Infarction (eTICI) score of 2c or 3 on the first pass, with the primary technique as adjudicated by core lab. The primary clinical outcome measure was a 90-day modified Rankin Scale (mRS) score of 0-2.</p><p><strong>Results: </strong>A total of 155 patients (10.4% of the ASSIST population) were included. Most patients had an M2 occlusion (93.5%). First pass eTICI reperfusion was achieved in 43.1% of the patients. No modifying effect of the frontline technique was found. The rate of mRS 0-2 (overall 65.0%) did not significantly differ between groups.</p><p><strong>Conclusion: </strong>The data suggests that the Trevo 3 mm SR and/or the AXS Catalyst 5 may be an option to treat medium distal vessel occlusion, but more data is needed to demonstrate safety and efficacy in this patient cohort. Further improvements are needed regarding materials and techniques to improve reperfusion results in this patient cohort in the future.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remote Teleproctoring with the TEGUS System for Mechanical Thrombectomy in a Non-Comprehensive Stroke Center: Initial Preliminary Data On Clinical Experience. 在非综合卒中中心使用 TEGUS 系统远程指导机械血栓切除术:临床经验的初步初步数据。
IF 2.4 3区 医学 Q2 CLINICAL NEUROLOGY Pub Date : 2024-08-23 DOI: 10.1007/s00062-024-01440-0
Maria Lourdes Diaz, Tomás Carmona, Manuel Requena, Carlos Piñana, David Hernández, Francesco Diana, Marta De Dios, Jordi Farrero, Marc Ribo, Arturo Fredes Araya, Laura Ludovica Gramegna, Francisco Purroy, Leandro Fernandez, Jordi Villalba, Manuel Quintana, Alejandro Tomasello

Purpose: Mechanical thrombectomy (MT) is typically performed by experienced neurointerventional radiologists. However, logistical and geographic limitations often hinder access to rapid MT. This study reports the first clinical experience using TEGUS teleproctoring to support MT conducted by general interventional radiologists (IR) at non-comprehensive stroke centers, compared to on-site proctoring outcomes.

Methods: The Arnau de Vilanova Hospital in Spain used to transfer stroke patients requiring MT to a comprehensive Stroke Center 160 km away. To overcome COVID-19 mobility restrictions, the Tegus Teleproctoring System was installed. Before teleproctoring, the general interventional radiologist underwent six months of neurointerventional training at a primary stroke center. From April 2021 to May 2023, general IR conducted MT either with on-site proctor supervision or teleproctoring support. We aim to compare clinical outcome of patients receiving MT according to proctoring method.

Results: During the study, 49 MTs were performed: 15 with TEGUS teleproctoring and 34 with on-site proctoring. Both groups had similar baseline characteristics, except for NIHSS scores (Tegus 9 [IQR 6-20] vs 18 [IQR 12-22], p = 0.034). No significant differences were found in door-to-revascularization time (82 ± 28.2 vs 84 ± 26.4) min, p = (0.895). The final mTICI distribution and 90-day mRS scores were comparable after adjusting by stroke severity. There were no reports of symptomatic intracranial hemorrhage in either group.

Conclusion: This study shows the feasibility of Tegus remote teleproctoring during emergent cases of MT in a remote hospital. It could improve the learning curve of interventional radiologists with limited experience in MT, and lower the territorial inequity associated to MT.

目的:机械血栓切除术(MT)通常由经验丰富的神经介入放射科医生实施。然而,后勤和地理位置的限制往往阻碍了快速进行机械取栓术。本研究报告了首次使用 TEGUS 远程监查支持非综合卒中中心普通介入放射医师(IR)进行机械取栓术的临床经验,并与现场监查结果进行了比较:西班牙 Arnau de Vilanova 医院曾将需要 MT 的中风患者转送到 160 公里外的综合中风中心。为了克服 COVID-19 的行动限制,医院安装了 Tegus 远程监考系统。在远程监查之前,普通介入放射科医生要在初级卒中中心接受六个月的神经介入培训。从 2021 年 4 月到 2023 年 5 月,普通介入放射医师在现场监查员监督或远程监查支持下进行 MT。我们旨在比较不同监考方式下接受MT患者的临床疗效:研究期间共进行了 49 次 MT:结果:研究期间共进行了 49 次 MT:15 次采用 TEGUS 远程监考,34 次采用现场监考。除 NIHSS 评分(Tegus 9 [IQR 6-20] vs 18 [IQR 12-22],P = 0.034)外,两组患者的基线特征相似。门到血管再通时间(82±28.2 vs 84±26.4)分钟,p = (0.895),无明显差异。根据中风严重程度进行调整后,最终的 mTICI 分布和 90 天 mRS 评分具有可比性。两组患者均无症状性颅内出血报告:本研究表明,在偏远医院的 MT 急诊病例中,Tegus 远程远程指导是可行的。结论:这项研究表明,在偏远地区医院的急诊病例中,Tegus 远程远程指导是可行的,它可以改善经验有限的介入放射科医生在 MT 方面的学习曲线,并降低与 MT 相关的地域不平等。
{"title":"Remote Teleproctoring with the TEGUS System for Mechanical Thrombectomy in a Non-Comprehensive Stroke Center: Initial Preliminary Data On Clinical Experience.","authors":"Maria Lourdes Diaz, Tomás Carmona, Manuel Requena, Carlos Piñana, David Hernández, Francesco Diana, Marta De Dios, Jordi Farrero, Marc Ribo, Arturo Fredes Araya, Laura Ludovica Gramegna, Francisco Purroy, Leandro Fernandez, Jordi Villalba, Manuel Quintana, Alejandro Tomasello","doi":"10.1007/s00062-024-01440-0","DOIUrl":"https://doi.org/10.1007/s00062-024-01440-0","url":null,"abstract":"<p><strong>Purpose: </strong>Mechanical thrombectomy (MT) is typically performed by experienced neurointerventional radiologists. However, logistical and geographic limitations often hinder access to rapid MT. This study reports the first clinical experience using TEGUS teleproctoring to support MT conducted by general interventional radiologists (IR) at non-comprehensive stroke centers, compared to on-site proctoring outcomes.</p><p><strong>Methods: </strong>The Arnau de Vilanova Hospital in Spain used to transfer stroke patients requiring MT to a comprehensive Stroke Center 160 km away. To overcome COVID-19 mobility restrictions, the Tegus Teleproctoring System was installed. Before teleproctoring, the general interventional radiologist underwent six months of neurointerventional training at a primary stroke center. From April 2021 to May 2023, general IR conducted MT either with on-site proctor supervision or teleproctoring support. We aim to compare clinical outcome of patients receiving MT according to proctoring method.</p><p><strong>Results: </strong>During the study, 49 MTs were performed: 15 with TEGUS teleproctoring and 34 with on-site proctoring. Both groups had similar baseline characteristics, except for NIHSS scores (Tegus 9 [IQR 6-20] vs 18 [IQR 12-22], p = 0.034). No significant differences were found in door-to-revascularization time (82 ± 28.2 vs 84 ± 26.4) min, p = (0.895). The final mTICI distribution and 90-day mRS scores were comparable after adjusting by stroke severity. There were no reports of symptomatic intracranial hemorrhage in either group.</p><p><strong>Conclusion: </strong>This study shows the feasibility of Tegus remote teleproctoring during emergent cases of MT in a remote hospital. It could improve the learning curve of interventional radiologists with limited experience in MT, and lower the territorial inequity associated to MT.</p>","PeriodicalId":49298,"journal":{"name":"Clinical Neuroradiology","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142047412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Neuroradiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1